Cardiovascular complications of breast cancer therapy.
Swain
Sandra M
SM
Washington Cancer Institute, Washington Hospital Center, Washington, DC, USA.
D020533:Angiogenesis Inhibitors / Q000009:adverse effects; D000970:Antineoplastic Agents / Q000009:adverse effects*; D001943:Breast Neoplasms / Q000188:drug therapy*; D002318:Cardiovascular Diseases / Q000139:chemically induced*; D002986:Clinical Trials as Topic; D005260:Female; D006801:Humans; D047428:Protein Kinase Inhibitors / Q000009:adverse effects
D020533:Angiogenesis Inhibitors; D000970:Antineoplastic Agents; D047428:Protein Kinase Inhibitors